Product Program year 2020 Source: CMS Open Payments

Inc280

Drug

Open in the dashboard

General payments

$563

11 payments

Research payments

$1,318,315

111 payments

Through program year 2020, $563 in general payments and $1,318,315 in research payments were reported against Inc280.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows

General

’19 ’20

Peak $296

Research

’19 ’20

Peak $729K

Year	Kind	Amount	Payments
2020	General	$267	6
2020	Research	$728,860	59
2019	General	$296	5
2019	Research	$589,456	52

Breakdown

Who paid General payments · program years 2019–2020

Novartis Pharmaceuticals Corporation $563 11 payments

Top recipients General payments · program year 2020

Jay Lee Thoracic Surgery (Cardiothoracic Vascular Surgery) · Los Angeles, CA $83 31% · 2 payments
Edward Garon Hematology & Oncology · Los Angeles, CA $46 17% · 1 payment
Jonathan Goldberg Hematology & Oncology · Brewster, NY $46 17% · 1 payment
Aaron Lisberg Hematology & Oncology · Santa Monica, CA $46 17% · 1 payment
Amy Cummings Hematology & Oncology · Torrance, CA $46 17% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020

Hematology & Oncology Internal Medicine $184 69% · 4 practitioners
Thoracic Surgery (Cardiothoracic Vascular Surgery) $83 31% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020

California $221 83% · 4 recipients
New York $46 17% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

Records

11 general · 111 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.